Raymond James Reiterates Strong Buy Rating on Tonix Pharma (TNXP)

September 22, 2026 5:06 AM

Raymond James analyst Tiago Fauth reiterated a Strong Buy rating and $27.00 price target on Tonix Pharma (NASDAQ: TNXP).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found